Anti-CD70-VC-rachelmycin ADC

This ADC product is comprised of an anti-CD70 monoclonal antibody conjugated via a VC linker to a rachelmycin. The rachelmycin is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, rachelmycin binds to DNA, causes DNA damage.